Cargando…

AB179. Tumor suppressor in lung cancer-1 is a prognostic predictor for the recurrence and progression of non-muscle-invasive bladder cancer

OBJECTIVE: To investigate the relationship between tumor suppressor in lung cancer-1 (TSLC1) expression and clinicopathological characteristics and evaluate its prognostic significance in patients with non-muscle-invasive bladder cancer (NMIBC). METHODS: TSLC1 expressions in 241 specimens of NMIBC w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yegang, Yang, Yongjiao, Liu, Li, Wang, Shangren, Liu, Xiaoqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2016
Materias:	Printed Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842727/ http://dx.doi.org/10.21037/tau.2016.s179

Ejemplares similares

AB175. Girdin protein is a novel prognosis predictor for patients with non-muscle invasive bladder cancer
por: Wu, Zhouliang, et al.
Publicado: (2016)

AB060. Lost expression of cell adhesion molecule 1 (CADM1) associated with bladder cancer progression and recurrence and its overexpression inhibited tumor cell malignant behaviors
por: Chen, Yegang, et al.
Publicado: (2016)

AB048. Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle invasive bladder cancer without carcinoma in situ
por: Cui, Jianfeng, et al.
Publicado: (2017)

AB095. Transurethral holmium laser bladder tumor submucosal dissection (HoL-BTSD) for non-muscle invasive bladder cancer
por: Weiguang, Liu, et al.
Publicado: (2018)

AB182. The value of extensive transurethral resection in the diagnosis and treatment of non-muscle invasive bladder cancer with respect to the recurrence at the first follow-up cystoscopy
por: Qie, Yunkai, et al.
Publicado: (2016)

AB176. Impact of squamous and/or glandular differentiation on recurrence and progression after transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2016)

AB139. Low-dose versus standard dose of bacillus Calmette-Guerin in the treatment of non-muscle invasive bladder cancer
por: Xu, Chuanliang
Publicado: (2016)

AB128. Inhibiting cell migration and cell invasion by silencing the transcription factor ETS-1 in human bladder cancer
por: Liu, Yuchen, et al.
Publicado: (2016)

AB161. Rottlerin-induced autophagy leads to the apoptosis in bladder cancer cells
por: Qi, Ping, et al.
Publicado: (2016)

AB180. Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection
por: Sha, Nan, et al.
Publicado: (2016)

AB168. Expression and clinical significance of CCAT2 in renal cell carcinoma and bladder cancer
por: Wu, Song, et al.
Publicado: (2016)

AB267. Association of genetic polymorphism of CCNE1 and RIP2 with bladder cancer risk
por: Liang, Enli
Publicado: (2016)

AB153. Down-regulated expression of excision of repair cross-complementing gene 1 reduces resistance to hydroxycamptothecine in bladder cancer
por: Liu, Yili
Publicado: (2016)

AB208. Can bladder irrigation reduce the morbidity of bladder stones in patients with spinal cord injury?
por: Chen, H, et al.
Publicado: (2016)

AB122. The structure and function of NKAIN2—a candidate tumor suppressor
por: Zhao, Shanchao, et al.
Publicado: (2016)

AB144. H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation
por: Liu, Changkun, et al.
Publicado: (2016)

AB160. Association of nineteen polymorphisms from seven DNA repair genes and the risk for bladder cancer in China
por: Zhu, Gongjian, et al.
Publicado: (2016)

AB152. Combination of intravesical chemotherapy and Bacillus Calmette-Guerin versus Bacillus Calmette-Guerin monotherapy in intermediate- and high-risk non-muscle invasive bladder cancer: a systematic review and meta-analysis
por: Cui, Jianfeng, et al.
Publicado: (2016)

AB232. The aetiology and efficacy of the treatment of persistent and recurrent hemospermia
por: Xiao, Hengjun, et al.
Publicado: (2016)

AB264. MiR-186 inhibits the malignant behaviours of urothelial bladder cancer cell lines by targeting HMGN5
por: Yao, Kun, et al.
Publicado: (2016)

AB178. Holmium laser resection of the distal ureter and bladder cuff during radical nephroureterectomy for patients with pelvis or ureteral cancer
por: Ge, Yongchao
Publicado: (2016)

AB147. Wild-type p53-induced phosphatase 1 is a prognostic marker and therapeutic target in bladder transitional cell carcinoma
por: Wang, Zhipeng, et al.
Publicado: (2016)

AB138. Experience on thulium laser treatment in transurethral resection of bladder tumor
por: Gan, Xiuguo, et al.
Publicado: (2016)

AB066. The diagnostic value of narrow-band imaging for flat bladder lesions
por: Chang, Yifan, et al.
Publicado: (2018)

AB071. Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases
por: Liu, Zhiyong, et al.
Publicado: (2018)

AB127. Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cell
por: Liu, Yuchen, et al.
Publicado: (2016)

AB143. Pharmacogenetic association between XRCC1 polymorphisms and improved outcomes in bladder cancer patients following intravesical instillation of epirubicin
por: Li, Pengchao, et al.
Publicado: (2016)

AB121. Role of bladder hydrodistention and intravesical sodium hyaluronate in the treatment of interstitial cystitis
por: Yang, Jin-Yi, et al.
Publicado: (2016)

AB130. The expression and clinical significance of HIF-1α in bladder urothelial carcinoma
por: Fan, Haitao
Publicado: (2016)

AB156. Seminal plasma protein in renal cell carcinoma: expression of semenogelin I is a predictor for cancer progression and prognosis
por: Zhang, Shengli, et al.
Publicado: (2016)

AB266. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer
por: Chen, Tao, et al.
Publicado: (2016)

AB150. Paraneoplastic cerebellar degeneration: an uncommon manifestation of urothelial carcinoma in situ of the urinary bladder
por: Zhu, Yaofeng, et al.
Publicado: (2016)

AB065. Confocal laser endomicroscopy for diagnosing malignant bladder tumour: a pilot study
por: Zhang, Zhensheng, et al.
Publicado: (2018)

AB056. Cytoreductive radical prostatectomy for men with oligo-metastatic prostate cancer
por: Liu, Shengjie, et al.
Publicado: (2017)

AB064. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer
por: Xu, Song, et al.
Publicado: (2017)

AB195. Correlations among improvements in overactive bladder symptom scores (OABSS) and urinary nerve growth factor levels in overactive bladder patients
por: Yang, Bo
Publicado: (2016)

AB258. Effect and mechanism of grape seed proanthocyanidin extract (GSPE) on diabetes-induced bladder dysfunction
por: Chen, Shouzhen, et al.
Publicado: (2016)

AB260. Role of µ, κ, and δ opioid receptors in tibial inhibition of bladder overactivity in cats
por: Zhang, Zhaocun, et al.
Publicado: (2016)

AB159. A C/T germline single-nucleotide polymorphism in the PARP1 gene is associated with survival of bladder cancer in a Gansu population-based study
por: Chen, Zhaohui, et al.
Publicado: (2016)

AB265. Association between MDM2 SNP309T>G polymorphism and the risk of bladder cancer: new data in Chinese population and an update meta-analysis
por: Xie, Linguo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f14gng1s8qt9haq3psh3e86qrm